Dr Arackal Manu Nair, who it is alleged gave prostate cancer treatment to patients who did not have the disease, is also being investigated by the UK's General Medical Council (GMC), it emerged today.
The consultant urologist is also alleged to have given some patients laser treatment - a high intensity focused ultrasound (HIFU) - which was yet to be approved by the UK's National Institute for Clinical Excellence (Nice).
The GMC has placed a number of restrictions on the doctor's license until July 2017.
The surgeon, who also worked at Spire Hospitals in Solihull, near Birmingham, resigned from the NHS Trust in July 2015.
"We would like to unreservedly apologise for any distress this has caused," a spokesperson for the trust said.
Lawyers representing former patients are now urging anyone who fears they may have suffered medical negligence to come forward by September 30.
Nair has also appeared on a television show in the UK called 'Embarrassing Bodies' as a medical expert.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
